Abstract
5-Aminolevulinic acid (5-ALA) is a precursor in the biosynthesis of haem. External application of 5-ALA leads to the formation of protoporphyrin IX, the last intermediate product before haem, which is an effective sensitiser. The 5-ALA-induced endogenous photosensitisation of tumour cells has been exploited for photodynamic therapy (PDT). Experimental human G-3 colonic tumours were transplanted into nude mice, and ten mice were treated by PDT. Ten animals served as controls. We measured a fluorescence intensity of the tumour that was about eight times higher than in the surrounding tissue; a good correlation between the fluorescence intensity and the photodynamic effect was found. Tumour growth was inhibited significantly after PDT, two tumours being destroyed completely after the second PDT treatment. In addition, on-line fluorescence detection during PDT showed a change in the intensity and the fluorescence spectrum of protoporphyrin IX caused by photobleaching and the formation of photoproducts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barr H, Tralau CJ, MacRobert AJ, Morrison I, Phillips D, Bown SG (1988) Fluorescence photometric techniques for determination of microscopic tissue distribution of phthalocyanine photosensitizers for photodynamic therapy. Lasers Med Sci 3:81–86
Barr H, Chatlani P, Tralau CJ, MacRobert AJ, Boulos PB, Bown SG (1991) Local eradication of rat colon cancer with photodynamic therapy: correlation of distribution of photosensitiser with biological effects in normal and tumour tissue. Gut 32:517–523
Bedwell J, MacRobert AJ, Phillips D, Bown SG (1992) Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br J Cancer 65:818–824
Charlsworth P, Truscott TG (1993) The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT). J Photochem Photobiol [B] 18:99–100
Divaris DXG, Kennedy JC, Pottier RH (1990) Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoprophyrin IX fluorescence. Am J Pathol 136:891–897
Henderson BW, Waldow SM, Mang TS, Potter WR, Malone B, Doughtery TJ (1985) Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following PDT. Cancer Res 45:572–576
Inhoffen HH, Brockmann H, Bliesener KM (1969) Photoprotoporpyrine und ihre Umwandlung in Spirographis sowie Isospirographis-Porphirin. Liebigs Ann Chem 730:173–185
Kelly JF, Snell ME, Berembaum MC (1975) Photodynamic destruction of human bladder carcinoma. Br J Cancer 31:237–244
Kennedy JC, Pottier RH (1992) Endogenous protoporphyrin IX, a clinical useful photosensitizer for photodynamic therapy. J Photochem Photobiol [B] 14:275–292
Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photoechem Photobiol [B] 6:143–148
König K, Wabnitz H, Dietel W (1990) Variation in the fluorescence decay properties of hematoporphyrin derivative during its conversion into photoproducts. J Photochem Photobiol [B] 8:103–111
König K, Schneckenburger H, Rück A, Steiner R (1993) In vivo photoproducts formation during PDT with ALA-induced endogenous porphyrins. J Photochem Photobiol [B] 18:287–290
Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG (1993) Oral versus intravenous administration of 5-amino-levulinic acid for photodynamic therapy. Br J Cancer 68:41–51
Malik Z, Djaldetti M (1979) 5-Aminolevulinic acid stimulation of porphyrin and hemoglobin synthesis by uninduced fried erythroleukaemic cells. Cell Differ 8:223–233
McGilvery RW, Goldstein G (eds) (1979) Biochemistry, functional approach. Saunders, Philadelphia London Toronto, pp 632–635
Peng Q, Moan J, Warloe T, Nesland JM, Rimington C (1992) Distribution and photosensitizing efficiency or porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 52:433–443
Schneckenburger H, Strauss W, Rück A, Seidlitz H, Wessels JM (1992) Microscopic fluorescence spectroscopy and diagnosis. Opt Eng 31:995–999
Seidlitz HK, Stettmaier K, Wessels JM, Schneckenburger H (1992) Intracellular fluorescence polarization, picosecond kinetics and light-induced reactions of photosensitizing porphyrins. Opt Eng 31:1482–1486
Sima AAF, Kennedy JC, Blakeslee D, Robertson DM (1981) Experimental porphyric neuropathy: a preliminary report. Can J Neurol Sci 8:105–113
Valat P, Reinhart GD, Jameson DM (1988) Application of time-resolved fluorometry to the resolution of porphyrine-product mixtures. Photochem Photobiol [B] 47:787–790
Yamashita M, Jomura M, Kobayashi S, Sato T (1984) Picosecond time resolved fluorescence spectroscopy of HPD. IEEE J Quantum Electron 20:1363–1369
Zalar GL, Poh-Fitzpatrick M, Krohn DL, Jacobs R, Harber LC (1977) Induction of drug photosensitisation in man after parenteral exposure to hematoporphyrin. Arch Dermatol 113:1392–1397
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Orth, K., König, K., Genze, F. et al. Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins. J Cancer Res Clin Oncol 120, 657–661 (1994). https://doi.org/10.1007/BF01245377
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01245377